Multiple endocrine neoplasia type 1

Cornelis J.M. Lips, Koen Dreijerink, Thera P. Links, Jo W.M. Höppener

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Scopus)

Abstract

Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal-dominant inherited tumor syndrome characterized by hyperplasia and/or tumors in the parathyroid glands, the pancreatic islets, the anterior pituitary and adrenal glands, as well as neuroendocrine tumors in the thymus, lungs and stomach, and tumors in nonendocrine tissues. In 1997, the responsible MEN1 gene was identified as a tumor-suppressor gene and its product was named menin. In this review, guidelines for early diagnosis, including MEN1 gene mutation analysis, and treatment, including periodic clinical monitoring, have been formulated, enabling improvement of life expectancy and quality of life. Identification of menin-interacting proteins has provided new insights into the function of menin, notably involving regulation of gene transcription related to proliferation and apoptosis, genome stability and DNA repair, and endocrine/metabolic homeostasis. In the near future, target-directed intervention may prevent or delay the onset of MEN 1-related tumors.

Original languageEnglish
Pages (from-to)371-388
Number of pages18
JournalExpert Review of Endocrinology and Metabolism
Volume4
Issue number4
DOIs
Publication statusPublished - 14 Sept 2009

Keywords

  • DNA diagnosis
  • Genetic testing
  • MEN 1
  • Menin
  • Multiple endocrine neoplasia type 1
  • Mutation analysis
  • Periodic clinical monitoring
  • Presymptomatic treatment

Cite this